10081--2/29/2008--BARR_PHARMACEUTICALS

related topics

{product, liability, claim}

{regulation, change, law}

{operation, international, foreign}

{cost, regulation, environmental}

{product, market, service}

{debt, indebtedness, cash}

{condition, economic, financial}

Impact on our revenues and profits as competition is introduced Impact of At Risk Launches Uncertainty associated with pharmaceutical pricing, reimbursement and related matters We have substantial indebtedness which requires us to apply a substantial portion of our cash flows from operation to service our indebtedness. Volatility in interest rates, commodity prices and credit markets may adversely affect our financial condition, result of operations or cash flows We are subject to risks associated with doing business outside of the United States We are subject to the restrictions imposed by the U.S. Foreign Corrupt Practices Act and similar worldwide anti-bribery laws Changes in foreign currency exchange rates may adversely affect our results Cost and Expense Control/Unusual Events Availability of Product Liability Insurance Exposure to Environmental Laws and Regulations Changes in Laws and Accounting Standards

Full 10-K form ▸

10081--2/29/2008--BARR_PHARMACEUTICALS_INC